Home-based online exercise program for people with pulmonary arterial hypertension
Tests an 8-week home exercise program done online in adults with pulmonary arterial hypertension.
Plain-language title generated from the registry record
Registry title: Telerehabilitation in Pulmonary Arterial Hypertension
Key facts
- Where
- Málaga, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stable pulmonary arterial hypertension (PAH) who can use a smartphone app for an 8-week home exercise program.
- Age
- 18 years or older
- Sex
- Men and women can join.
- Disease stage
- Stable pulmonary arterial hypertension (PAH). The summary mentions Group 1 PAH, WHO functional class II-III.
Main reasons for not taking part
- Sudden unstable heart or lung problems, or a medical reason not to exercise
- Memory or thinking problems or a mental health condition that prevents understanding or using the program
- Taking part in another interventional clinical trial at the same time
Read by machine on 9 November 2026.
Where in Spain
- FIMABISMálaga, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Trial code
- NCT07799675
- Record updated
- 2 September 2026
- Original description
Context: Pulmonary arterial hypertension (PAH) causes severe exercise intolerance and reduced quality of life, while access to supervised rehabilitation remains limited.Read full original descriptionShow less
Efficacy, Safety and Effect on the Inflammatory State of a Telerehabilitation Program in Patients With Hypertension Pulmonary Artery
Context: Pulmonary arterial hypertension (PAH) causes severe exercise intolerance and reduced quality of life, while access to supervised rehabilitation remains limited.
Objective: Evaluate the safety, feasibility, and clinical effects of an 8-week structured home-based telerehabilitation program in stable PAH patients. Methods: A multicenter, prospective, single-arm study including 34 adults with Group 1 PAH (WHO functional class II-III) performing three weekly exercise sessions via a digital platform.
Outcomes: The primary endpoint is peak oxygen consumption (VO₂peak) via cardiopulmonary exercise testing, alongside 6-minute walk distance, quality of life questionnaires, inflammatory biomarkers, and safety tracking.
Inclusion: Confirmed diagnosis of stable pulmonary arterial hypertension (PAH); Age 18 years or older; Ability to use a smartphone or mobile application for the telerehabilitation program; Signed informed consent.
Exclusion: Cognitive impairment or psychiatric disorders preventing comprehension or use of the telerehabilitation program; Acute cardiorespiratory instability or medical contraindication to physical exercise; Simultaneous participation in another interventional clinical trial.